Description
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following:
- The Worldwide IVD Market, 2019-2024
- Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China
- Genetic Testing
- New POC Innovations
- Cancer Testing and Personalized Medicine
- Hematology
- Glucose Monitoring Advancements
- HbA1c Testing
- New Developments in Infectious Diseases
- Cytology – Increasing Molecular Dx Options
- Blood Bank Markets
- Synovial Fluid Testing
- Transplant Diagnostics
- Tick-Borne Diseases: Babesiosis
- Parasites
- Industry Partnerships and Collaborations
Table of Contents
Introduction
-
- Figure 1-1: The Worldwide IVD Market, 2019 -2024 ($millions)
-
- Figure 1-2: Regional Distribution of IVD Market, 2019 (N. America, Europe, Japan, China, RoW)
North America
EU15/Western Europe
Eastern Europe
Japan
China
Genetic Testing
New POC Innovations
Cancer Testing and Personalized Medicine
Hematology
Glucose Monitoring Advancements
HbA1c Testing
New Developments in Infectious Diseases
- Ebola Testing
- Hepatitis C Testing
- HIV Testing
- Molecular Diagnostics Innovations for Infectious Diseases
- Respiratory Viruses
- Sepsis
- STDs
- Zika Virus Testing
Cytology – Increasing Molecular Dx Options
Blood Bank Markets
Synovial Fluid Testing
Transplant Diagnostics
Tick-Borne Diseases
Parasites
Latest Industry Activity
- Abbott Diagnostics and Intoximeters
- Agilent Acquires BioTek Instruments
- Adaptive Biotechnologies and Illumina
- AroCell AB and Diapharma Group
- Beckman Coulter and Cytobank
- BGI Genomics and Pryzm Health
- CareDx and Cibiltech
- Exact Sciences Buys Genomic Health
- Illumina and Qiagen Partnership
- Invitae and Singular Bio
- LabCorp Sells Qiagen’s Companion Dx
- NeuMoDx and SelfScreen
- Meridian Bioscience and GenePOC
- Qiagen Launches APIS Assay Technologies, Ltd.
- Qiagen and Inovio Pharmaceuticals
- Qiagen Collaborates with DiaSorin
- Thermo Fisher Scientific and HighChem Ltd.
- Companies Buy to Grow
- Gene Editing
